QQ客服 官方微博 反馈留言

	EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs)
	Soo, R.; Mok, T. S. K.; Shi, Y-K.; Zhang, L.; Lu, S.; Yang, J. C-H.; Nakagawa, K.; Yamamoto, N.; Nokihara, H.; Sugawara, S.
	2017
会议名称	ANNALS OF ONCOLOGY
会议日期	2017-11-01
收录类别	CPCI-S
URL标识	查看原文
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/6372898
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Soo, R.,Mok, T. S. K.,Shi, Y-K.,et al. EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs)[C]. 见:ANNALS OF ONCOLOGY. 2017-11-01.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。